Arrowhead Pharmaceuticals (ARWR) Land & Improvements (2021 - 2022)

Arrowhead Pharmaceuticals (ARWR) posted Land & Improvements of $3.0 million for Q1 2022, little changed on a QoQ basis from $3.0 million in Q4 2021.

Arrowhead Pharmaceuticals (ARWR) Land & Improvements (2021 - 2022) Analysis & Trends

Arrowhead Pharmaceuticals' Land & Improvements history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arrowhead Pharmaceuticals 11.98 Bn 10.18 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn